Literature DB >> 23583930

NMDA receptors in nervous system diseases.

Qiang Zhou1, Morgan Sheng.   

Abstract

NMDA receptor (NMDAR) dysfunction has emerged as a common theme in several major nervous system disorders, including ischemic brain injury, chronic neurodegenerative diseases, pain, depression and schizophrenia. Either hyperactivity or hypofunction of NMDARs could contribute to disease pathophysiology. It is likely that distinct subtypes of NMDARs (as defined by subunit composition and/or subsynaptic location) are differentially involved in central nervous system diseases. Here we focus on a few examples of nervous system diseases where the contribution of NMDARs is relatively well characterized and discuss the implications for potential treatment of these illnesses. This article is part of the Special Issue entitled 'Glutamate Receptor-Dependent Synaptic Plasticity'.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Glutamate; Neurodegeneration; Synaptic plasticity; Synaptic transmission

Mesh:

Substances:

Year:  2013        PMID: 23583930     DOI: 10.1016/j.neuropharm.2013.03.030

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  88 in total

1.  Regulation of neuronal gene expression and survival by basal NMDA receptor activity: a role for histone deacetylase 4.

Authors:  Yelin Chen; Yuanyuan Wang; Zora Modrusan; Morgan Sheng; Joshua S Kaminker
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

2.  Dynorphin up-regulation in the dentate granule cell mossy fiber pathway following chronic inhibition of GluN2B-containing NMDAR is associated with increased CREB (Ser 133) phosphorylation, but is independent of BDNF/TrkB signaling pathways.

Authors:  W Bradley Rittase; Yu Dong; DaRel Barksdale; Zygmunt Galdzicki; Suzanne B Bausch
Journal:  Mol Cell Neurosci       Date:  2014-04-23       Impact factor: 4.314

Review 3.  Molecular bases of NMDA receptor subtype-dependent properties.

Authors:  Nathan G Glasgow; Beth Siegler Retchless; Jon W Johnson
Journal:  J Physiol       Date:  2014-09-09       Impact factor: 5.182

4.  Use of the 4-Hydroxytriazole Moiety as a Bioisosteric Tool in the Development of Ionotropic Glutamate Receptor Ligands.

Authors:  Stefano Sainas; Piero Temperini; Jill C Farnsworth; Feng Yi; Stine Møllerud; Anders A Jensen; Birgitte Nielsen; Alice Passoni; Jette S Kastrup; Kasper B Hansen; Donatella Boschi; Darryl S Pickering; Rasmus P Clausen; Marco L Lolli
Journal:  J Med Chem       Date:  2019-04-18       Impact factor: 7.446

5.  Autoimmune receptor encephalitis in mice induced by active immunization with conformationally stabilized holoreceptors.

Authors:  Brian E Jones; Kenneth R Tovar; April Goehring; Farzad Jalali-Yazdi; Nana J Okada; Eric Gouaux; Gary L Westbrook
Journal:  Sci Transl Med       Date:  2019-07-10       Impact factor: 17.956

6.  Effects of α7 Nicotinic Receptor Activation on Cell Survival in Rat Organotypic Hippocampal Slice Cultures.

Authors:  Denise F Happ; R Andrew Tasker
Journal:  Neurotox Res       Date:  2017-12-22       Impact factor: 3.911

7.  D-Serine Potently Drives Ligand-Binding Domain Closure in the Ionotropic Glutamate Receptor GluD2.

Authors:  Alfred C Chin; Remy A Yovanno; Tyler J Wied; Ariel Gershman; Albert Y Lau
Journal:  Structure       Date:  2020-07-30       Impact factor: 5.006

Review 8.  Dissecting diverse functions of NMDA receptors by structural biology.

Authors:  Jue Xiang Wang; Hiro Furukawa
Journal:  Curr Opin Struct Biol       Date:  2019-01-28       Impact factor: 6.809

9.  Modulating synaptic NMDA receptors.

Authors:  Kenneth R Tovar; Gary L Westbrook
Journal:  Neuropharmacology       Date:  2016-08-23       Impact factor: 5.250

10.  Surgical incision-induced nociception causes cognitive impairment and reduction in synaptic NMDA receptor 2B in mice.

Authors:  Xiaoqin Zhang; Xin Xin; Yuanlin Dong; Yiying Zhang; Buwei Yu; Jianren Mao; Zhongcong Xie
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.